Decline in genital warts diagnoses among young women and young men since the introduction of the bivalent HPV (16/18) vaccination programme in England: An ecological analysis

Sexually Transmitted Infections

Volumn 93, Issue 2, 2017, Pages 125-128

  Canvin, M ^a   Sinka, K ^a   Hughes, G ^a   Mesher, D ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

GENITAL WARTS; HPV; VACCINATION

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; AGE; ARTICLE; CONDYLOMA ACUMINATUM; ENGLAND; FEMALE; HETEROSEXUAL MALE; HUMAN; INCIDENCE; INFECTION PREVENTION; MALE; MEN WHO HAVE SEX WITH MEN; PRIORITY JOURNAL; SEXUAL ORIENTATION; VACCINATION; YOUNG ADULT; CONDYLOMATA ACUMINATA; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; IMMUNOLOGY; PREVENTIVE HEALTH SERVICE; PROGRAM EVALUATION; STATISTICS AND NUMERICAL DATA; VIROLOGY;

ADOLESCENT; CONDYLOMATA ACUMINATA; ENGLAND; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; IMMUNIZATION PROGRAMS; MALE; PAPILLOMAVIRUS VACCINES; PROGRAM EVALUATION; VACCINATION; YOUNG ADULT;

EID: 84979018981     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sextrans-2016-052626     Document Type: Article

References (16)

1. Public Health England. Human Papillomavirus (HPV) Vaccine Coverage in England, 2008/09 to 2013/14: A review of the full six years of the three-dose schedule. 2015. https://www. gov. uk/government/uploads/system/uploads/attachment-data/file/ 412264/HPV-Vaccine-Coverage-in-England-200809-to-201314. pdf (accessed Mar 2016).
2. Harper DM, Franco EL, Wheeler CM, et al. Sustained efficacy up to 4. 5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 2006;367:1247-55.
3. Villa LL, Costa RL, Petta CA, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: A randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005;6:271-8.
4. Hawkins MG, Winder DM, Ball SL, et al. Detection of specific HPV subtypes responsible for the pathogenesis of condylomata acuminata. Virol J 2013;10:137.
5. Public Health England. Continuing trend of declining genital warts diagnoses in young women in England associated with HPV 16/18 vaccination: update to end-2014, in Health Protection Report. 2015. https://www. gov. uk/government/ publications/health-protection-report-volume-9-2015/hpr-volume-9-issue-22-news-26-june (accessed Mar 2015).
6. Howell-Jones R, Soldan K, Wetten S, et al. Declining genital Warts in young women in England associated with HPV 16/18 vaccination: An ecological study. J Infect Dis 2013;208:1397-403.
7. Savage EJ, Mohammed H, Leong G, et al. Improving surveillance of sexually transmitted infections using mandatory electronic clinical reporting: The genitourinary medicine clinic activity dataset, England, 2009 to 2013. Euro Surveill 2014;19:20981.
8. Office for National Statistics. Mid-2001 to Mid-2013 Population Estimates: Single year of age and sex for local authorities in the United Kingdom; estimated resident population. 2014. http://www. ons. gov. uk/peoplepopulationandcommunity/ populationandmigration/populationestimates/bulletins/ annualmidyearpopulationestimates/2014-06-26 (accessed Mar 2016).
9. Mercer CH, Tanton C, Prah P, et al. Changes in sexual attitudes and lifestyles in Britain through the life course and over time: findings from The National Surveys of Sexual Attitudes and Lifestyles (Natsal). Lancet 2013;382:1781-94.
10. Public Health England. Sexually transmitted infections (STIs): Annual data tables. 2015. https://www. gov. uk/government/statistics/sexually-transmitted-infections-stisannual-data-tables (accessed Mar 2016).
11. Wilson B, Smallwood S. Age differences at marriage and divorce. Popul Trends 2008;(132):17-25.
12. Szarewski A, Skinner SR, Garland SM, et al. Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against low-risk HPV types (PATRICIA randomized trial): An unexpected observation. J Infect Dis 2013;208:1391-6.
13. Petras M, Adamkova V. Impact of quadrivalent human papillomavirus vaccine in women at increased risk of genital warts burden: Population-based cross-sectional survey of Czech women aged 16 to 40 years. Vaccine 2015;33:6264-7.
14. Hughes G, Field N. The epidemiology of sexually transmitted infections in the UK: impact of behavior, services and interventions. Future Microbiol 2015;10:35-51.
15. Desai S, Wetten S, Woodhall SC, et al. Genital warts and cost of care in England. Sex Transm Infect 2011;87:464-8.
16. Ali H, Donovan B, Wand H, et al. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. BMJ 2013;346:f2032.